TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4 (Tβ4) — a naturally occurring protein found in virtually every cell in the body. It is one of the most extensively studied peptides for wound healing, inflammation regulation, and tissue repair across cardiovascular, musculoskeletal, and neurological applications.
What Is TB-500?
Thymosin Beta-4 is a 43-amino acid protein encoded by the TMSB4X gene, present in high concentrations in platelets, white blood cells, and tissues undergoing active repair. TB-500 refers to a 17-amino acid fragment of Thymosin Beta-4 (amino acids 17–23 extended) that retains much of the parent molecule’s bioactivity with improved solubility.
Mechanisms of Action
Actin Regulation: TB-500’s primary mechanism centers on G-actin binding, regulating actin polymerization and cell motility — critical for cell migration to wound sites, tissue remodeling, and angiogenesis.
Anti-Inflammatory Activity: Downregulates pro-inflammatory cytokines including NF-κB-mediated signaling, reducing chronic inflammation that impairs healing.
Stem Cell Activation: Promotes mobilization and homing of stem cells — particularly cardiac stem cells and endothelial progenitor cells — to sites of injury.
Angiogenesis: Upregulates VEGF and other angiogenic factors, improving vascular supply to damaged areas.
Key Research Findings
Cardiac Healing: In myocardial infarction animal models, Thymosin Beta-4 reduced infarct size, improved cardiac function, promoted cardiomyocyte survival, and activated cardiac progenitor cells — making it a significant subject in regenerative cardiology.
Wound Healing: Studies consistently show accelerated wound closure, improved collagen deposition quality, and reduced scar formation in both acute and chronic wound models.
Musculoskeletal Repair: Reduces inflammation, accelerates satellite cell activation, and improves functional recovery in muscle injury models. Tendon and ligament research shows improved healing kinetics.
Neurological: Preclinical research shows reduced neuroinflammation in TBI models, axonal regeneration in spinal cord injury, and neurogenesis promotion in stroke models.
Eye Research: Studied for corneal wound healing and dry eye, showing reduced inflammation and accelerated epithelial repair.
The BPC-157 + TB-500 Stack
The combination of BPC-157 and TB-500 is one of the most studied peptide combinations in the research community. BPC-157’s angiogenic and NO-mediated effects combined with TB-500’s actin-regulation and stem cell mobilization address multiple stages of the tissue repair cascade simultaneously. Both are available from Combat Research in research-grade purity.
Conclusion
TB-500 stands as one of the most comprehensively researched repair peptides, with literature spanning cardiac, musculoskeletal, neurological, and dermatological applications. Its unique actin-regulatory mechanism distinguishes it from other healing peptides.
For research purposes only. Not for human therapeutic use.
Related Research Articles
- BPC-157: The Complete Research Guide
- Best Peptides for Muscle Growth
- The Complete Guide to Peptide Stacking
Shop TB-500 at Combat Research
Research-grade TB-500 (Thymosin Beta-4 fragment) at ≥99% purity. Third-party verified. USA domestic sourcing.
